BACKGROUND: The purpose of this study was to characterize the expression of CD200, a membrane protein that functions in immune evasion, to examine its correlations with cancer stem cell (CSC)-like features and analyze its response to chemotherapy and radiation in human papillomavirus (HPV)-positive (+) and negative (-) head and neck squamous cell carcinomas (HNSCCs). METHODS: CD200 expression was analyzed in several HNSCC cell lines. CD200 was overexpressed in HPV(+) murine tonsil epithelial cells, its effects on Shh and Bmi-1 were examined in vitro, and tumor growth and response to chemoradiation were analyzed in vitro and in vivo. RESULTS: CD200 was diversely expressed and consistently associated with expression of Bmi-1 and Shh. Overexpression of CD200 induced Bmi-1 and Shh. Tumors grew similarly between C57BL/6 and Rag1(-/-) C57BL/6 mice. CD200 expression enhanced the resistance to chemoradiation only in vivo. CONCLUSION: CD200 was related to CSC features and modulates response to chemoradiation in vivo. Attenuating this might be a potential therapeutic strategy.
BACKGROUND: The purpose of this study was to characterize the expression of CD200, a membrane protein that functions in immune evasion, to examine its correlations with cancer stem cell (CSC)-like features and analyze its response to chemotherapy and radiation in human papillomavirus (HPV)-positive (+) and negative (-) head and neck squamous cell carcinomas (HNSCCs). METHODS:CD200 expression was analyzed in several HNSCC cell lines. CD200 was overexpressed in HPV(+) murine tonsil epithelial cells, its effects on Shh and Bmi-1 were examined in vitro, and tumor growth and response to chemoradiation were analyzed in vitro and in vivo. RESULTS:CD200 was diversely expressed and consistently associated with expression of Bmi-1 and Shh. Overexpression of CD200 induced Bmi-1 and Shh. Tumors grew similarly between C57BL/6 and Rag1(-/-) C57BL/6 mice. CD200 expression enhanced the resistance to chemoradiation only in vivo. CONCLUSION:CD200 was related to CSC features and modulates response to chemoradiation in vivo. Attenuating this might be a potential therapeutic strategy.
Authors: R M Hoek; S R Ruuls; C A Murphy; G J Wright; R Goddard; S M Zurawski; B Blom; M E Homola; W J Streit; M H Brown; A N Barclay; J D Sedgwick Journal: Science Date: 2000-12-01 Impact factor: 47.728
Authors: William C Spanos; Paul Nowicki; Dong Wook Lee; Andrew Hoover; Bruce Hostager; Anjali Gupta; Mary E Anderson; John H Lee Journal: Arch Otolaryngol Head Neck Surg Date: 2009-11
Authors: Anders Näsman; Per Attner; Lalle Hammarstedt; Juan Du; Mathilda Eriksson; Geraldine Giraud; Sofie Ahrlund-Richter; Linda Marklund; Mircea Romanitan; David Lindquist; Torbjörn Ramqvist; Johan Lindholm; Pär Sparén; Weimin Ye; Hanna Dahlstrand; Eva Munck-Wikland; Tina Dalianis Journal: Int J Cancer Date: 2009-07-15 Impact factor: 7.396
Authors: Yaroslav R Efremov; Anastasia S Proskurina; Ekaterina A Potter; Evgenia V Dolgova; Oksana V Efremova; Oleg S Taranov; Aleksandr A Ostanin; Elena R Chernykh; Nikolay A Kolchanov; Sergey S Bogachev Journal: Front Genet Date: 2018-11-16 Impact factor: 4.599
Authors: McLane J Watson; Paolo D A Vignali; Steven J Mullett; Abigail E Overacre-Delgoffe; Ronal M Peralta; Stephanie Grebinoski; Ashley V Menk; Natalie L Rittenhouse; Kristin DePeaux; Ryan D Whetstone; Dario A A Vignali; Timothy W Hand; Amanda C Poholek; Brett M Morrison; Jeffrey D Rothstein; Stacy G Wendell; Greg M Delgoffe Journal: Nature Date: 2021-02-15 Impact factor: 69.504
Authors: Shilpa Bhatia; Diemmy Nguyen; Laurel B Darragh; Benjamin Van Court; Jaspreet Sharma; Michael W Knitz; Miles Piper; Sanjana Bukkapatnam; Jacob Gadwa; Thomas E Bickett; Shiv Bhuvane; Sophia Corbo; Brian Wu; Yichien Lee; Mayumi Fujita; Molishree Joshi; Lynn E Heasley; Robert L Ferris; Olga Rodriguez; Christopher Albanese; Mohit Kapoor; Elena B Pasquale; Sana D Karam Journal: Nat Commun Date: 2022-06-20 Impact factor: 17.694
Authors: Iasha Z Khan; Christina A Del Guzzo; Anqi Shao; Jiyoon Cho; Rong Du; Adrienne O Cohen; David M Owens Journal: Cancer Res Date: 2021-06-28 Impact factor: 12.701